Biomarkers of the Future Conference: From bedside to practice

bmf-2021

The BMF 2021 will bring together a number of international key opinion leaders, all experts within in their individual fields of life science research, along with young fellows, senior researchers and industry partners, all focusing on biomarker discovery and research. The meeting will be directed to the application of high-throughput targeted proteomics as a key tool to understand biology and pathophysiology, as well as identify protein biomarkers for early diagnosis and progression of our major complex diseases.

Due to travel restrictions, the conference will take place exceptionally in a virtual format using a custom-made, state-of-the-art platform to maintain the high quality scientific content, the networking opportunities and the young fellows competition.

Key Talks

Tuesday 23rd November 2021

Session 3:

Biomarkers are eagerly needed to reduce global cardiovascular in women
Birgit Vogel – Mount Sinai Morningside

Biomarkers are eagerly needed in Cardio-oncology
Alain Cohen-Solal – University of Paris

Wednesday 24th November 2021

Session 5:

Integrating proteomics with other omics for clinical insights
Claudia Langenberg – University of Cambridge

Omics in the follow-up of heart failure patients
Isabella Kardys – Erasmus University Medical Centre

Session 6:

Next generation plasma proteome profiling
Mathias Uhlén – Royal Institute of Technology

2947

Biomarker assays

~475 million

Protein data points generated

662

Publications listed on website

35

Certified Core Labs

Contact us!